Soliqua (Lixi Lan): Sustained Long Term Cost Efficacy and Safety When Used in Combination with Metformin and Glimepiride
Udaya M. Kabadi & Sarah Exley · Journal of Advances in Medical and Pharmaceutical Sciences · 2021
Background: Previous studies using basal insulin documented the lowest daily dose and least hypoglycemic events when combined with Glimepiride and Metformin while attaining desirable glycemic control. However, Pivotal trials with Soliqua excluded Glimepiride as a part of therapy...
Open access
Research Article
10.9734/jamps/2021/v23i1030263